Viewing Study NCT04040816


Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2025-12-26 @ 11:49 AM
Study NCT ID: NCT04040816
Status: COMPLETED
Last Update Posted: 2021-11-05
First Post: 2019-07-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients
Sponsor: Shanton Pharma Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-01-01
Start Date Type: ACTUAL
Primary Completion Date: 2020-08-01
Primary Completion Date Type: ACTUAL
Completion Date: 2020-08-30
Completion Date Type: ACTUAL
First Submit Date: 2019-07-17
First Submit QC Date: None
Study First Post Date: 2019-08-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-11-04
Last Update Post Date: 2021-11-05
Last Update Post Date Type: ACTUAL